Lenvatinib en Cáncer Diferenciado de Tiroides: Respuestas tras la Refractariedad al Radioyodo - page 12

PFS by Previous VEGF-Targeted Therapy
Schlumberger M, et al.
N Engl J Med
2015
VEGF-naïve subgroup
Prior VEGF-treated subgroup
1...,2,3,4,5,6,7,8,9,10,11 13,14,15,16,17,18,19,20,21,22,...27
Powered by FlippingBook